Instruction for use: Sonizin

Trade name of the drug – Sonizin

Active substance: Tamsulosinum

Dosage Form: The modified-release capsules

Composition (per tablet):

Tamsulosin hydrochloride - 0.4 mg

Other ingredients: calcium stearate - 0.8 mg; triethyl citrate - 1.1 mg; Talc - 2.5 mg; a copolymer of ethyl acrylate and methacrylic acid (1: 1) (containing also polysorbate 80 - 1 mg, sodium lauryl sulfate - 0.3 mg) - 43.8 mg; MCC - 281.4 mg

hard gelatin capsule

body: iron oxide yellow (C.I. 77492, E172) - 0.1714%; titanium dioxide (C.I. 77891, E171) - 3%; iron oxide black (C.I. 77499, E172) - 0.01%; iron oxide red (C.I. 77491, E172) - 0.01%; Gelatin - 100%

cap: iron oxide red (C.I. 77491, E172) - 0.93%; iron oxide black (C.I. 77499, E172) - 0.53%; iron oxide yellow (C.I. 77492, E172) - 0.2%; titanium dioxide (C.I. 77891, E171) - 0.3333%; Gelatin - 100%

Description of Sonizin: Modified release capsule, 0.4 mg. The blister PVC / PVDC film and aluminum foil for 10 pcs. 1 or 3 blisters in a carton box.

Pharmacotherapeutic group: Alpha1-blocker [alpha-blockers]

Alpha1-blocker [Drugs affecting the metabolism of the prostate gland and correctors urodynamics]

ATX G04CA02 Tamsulosin

The nosological classification (ICD-10)

N40 Hyperplasia of prostate: Prostate adenoma; BPH; Prostatauxe; prostate Hypertrophy; Dysuric disorders caused by benign prostatic hyperplasia; Dizuricheskie disorder with benign prostatic hyperplasia; Dysuria with prostate cancer; Benign prostatic giperpalaziya; Benign prostatic hyperplasia; Benign prostatic hyperplasia stages 1 and 2; Benign prostatic hyperplasia I degree; Benign prostatic hyperplasia II degree; Benign prostatic hypertrophy; The disease of the prostate gland; Acute urinary retention related to benign prostatic hyperplasia; Benign prostatic hyperplasia stages 1 and 2 in combination with prostatitis; paradoxical ischuria

R30.0 Dysuria: Disorders after prostatectomy; dysuric disorder; Dysuric disorders caused by benign prostatic hyperplasia; dysuric symptoms; dizuricheskie disorder; Dizuricheskie disorder in men; Dysuria with prostate cancer; disorders of urination; dysuria; Dizuricheskie disorder with benign prostatic hyperplasia; Acute dysuria

Pharmacological Properties of Sonizin

Pharmachologic effect - Mode of action - alpha adrenoliticheskoe, antidizuricescoe.

Sonizin Dosage and Administration

Inside, after eating, 1 caps. per day, in one and the same time of day, drinking plenty of water. The capsule should neither apart crush or grind, as wherein the broken sustained release of the active substance.

Manufacturer

"Gedeon Richter Romania" SA, Romania. Romania, 540306, Targu Mures, Str. Cuza Voda number 99-105.

EN Owner: JSC "Gedeon Richter". Budapest, Hungary.

Claims consumer guide at the Moscow Representation of "Gedeon Richter". 119049, Moscow, 4th Dobryninsky per., 8.

Tel .: (495) 363-39-50; fax: (495) 363-39-49.

Storage conditions of Sonizin

At a temperature of 15-30 ° C. In its original packaging.

Keep out of the reach of children.

Shelf life

3 years.

Do not use beyond the expiration date printed on the package.

Conditions of supply of pharmacies

On prescription.